-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
【Abstract】Intrahepatic cholangiocarcinoma (ICC) originates from intrahepatic bile duct epithelial cells, second only to the incidence of hepatocellular carcinoma, and ranks second in liver malignancies
.
Radical resection is still the only possible method before treatment.
【Abstract】Intrahepatic cholangiocarcinoma (ICC) originates from intrahepatic bile duct epithelial cells, second only to the incidence of hepatocellular carcinoma, and ranks second in liver malignancies
For inoperable patients, adjuvant therapy, liver transplantation, ablation therapy, and targeted immunotherapy can be used to prolong the survival time of patients.
Therefore, radical resection and palliative treatment are of vital importance for the treatment of intrahepatic cholangiocarcinoma
.
Therefore, radical resection and palliative treatment are of vital importance for the treatment of intrahepatic cholangiocarcinoma
.
To sum up, intrahepatic cholangiocarcinoma is a type with high malignancy, difficult treatment and poor prognosis
.
.
To sum up, intrahepatic cholangiocarcinoma is a type with high malignancy, difficult treatment and poor prognosis
Leave a message here